Implications of Differential Expression of β-Catenin in Oral Carcinoma.
By: Miguel Angel Gonzalez Moles, José Antonio Gil Montoya, Maria Dolores Martín Salvago, Isabel Ruiz Ávila, Juan José Plaza Campillo, Manuel Bravo

School of Dentistry, Granada Biomedicine Institute, University of Granada, Granada, Spain magonzal@ugr.es.
2016-1-12; doi:
Abstract

Background

Alterations of β-catenin can promote cancer progression, but there has been little analysis of this protein in oral squamous cell carcinoma (OSCC). The objective of this study was to investigate the role of β-catenin in OSCC development.

Materials

Expression of β-catenin and Ki-67 from 92 OSCC was immunohistochemically studied in tissues close to the tumor invasion point and, in 37 cases, in tissues distant from the invasion point.

Results

Loss of membranous β-catenin expression was observed in 77.2% of "close" samples and 94.4% of "distant" samples. Nuclear β-catenin expression was detected in 35.9% of adjacent samples and 44.4% of "distant" samples. Nuclear β-catenin expression in ≥10% of cells was observed in 6.6% of "close" samples and 25% of "distant" samples. No relationship was found between β-catenin expression and cell proliferation.

Conclusion

β-Catenin plays a major oncogenic role in OSCC, principally through increase in invasiveness due to loss of its membranous expression.



Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

PMID:27069136






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements